Gyre Therapeutics Inc
(GYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,178 | -30,055 | -21,561 | -16,945 | -14,762 |
| Depreciation Amortization | 146 | 149 | 173 | 389 | 470 |
| Accounts receivable | -15,000 | N/A | 7 | 461 | -79 |
| Accounts payable and accrued liabilities | 3,031 | 500 | -90 | -102 | -4,273 |
| Other Working Capital | 8,215 | -1,369 | 567 | 836 | -6,260 |
| Other Operating Activity | 15,173 | 2,222 | 964 | -3,111 | 5,786 |
| Operating Cash Flow | $-43,613 | $-28,553 | $-19,940 | $-18,472 | $-19,118 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -129,977 | -198,912 | -25,472 | -3,399 | N/A |
| PPE Investments | -64 | -376 | -23 | 2,096 | -272 |
| Sale Of Investment | 157,433 | 127,967 | 14,300 | N/A | 13,823 |
| Other Investing Activity | 0 | 0 | 0 | -5 | 23,806 |
| Investing Cash Flow | $27,392 | $-71,321 | $-11,195 | $-1,308 | $37,357 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,888 |
| Debt Repayment | N/A | -5,082 | N/A | -14,340 | -3,020 |
| Common Stock Issued | 327 | 116,414 | 16,837 | 958 | 13 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -82 |
| Other Financing Activity | 0 | 0 | 4,245 | 14,330 | 10,514 |
| Financing Cash Flow | $327 | $111,332 | $21,082 | $948 | $9,313 |
| Beginning Cash Position | 31,263 | 19,805 | 29,858 | 29,096 | 1,544 |
| End Cash Position | 15,369 | 31,263 | 19,805 | 10,264 | 29,096 |
| Net Cash Flow | $-15,894 | $11,458 | $-10,053 | $-18,832 | $27,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,613 | -28,553 | -19,940 | -18,472 | -19,118 |
| Capital Expenditure | -64 | -376 | -23 | -468 | -272 |
| Free Cash Flow | -43,677 | -28,929 | -19,963 | -18,940 | -19,390 |